Global 3D Printing Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global 3D Printing Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
3D printing drugs can realize the advantages of precise control of drug dosage and precise control of release time, which has become one of the focuses of the pharmaceutical industry. The market potential is huge, so the number of companies entering the industry is increasing.
3D Printing Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global 3D Printing Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oral Solid Dosage Form and Non-Oral Solid Dosage Form are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for 3D Printing Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, 3D Printing Drug key manufacturers include Aprecia Pharmaceuticals, Triastek, FabRx and Multiply Labs, etc. Aprecia Pharmaceuticals, Triastek, FabRx are top 3 players and held % sales share in total in 2022.
3D Printing Drug can be divided into ZipDose, MED, FDM and SSE, etc. ZipDose is the mainstream product in the market, accounting for % sales share globally in 2022.
3D Printing Drug is widely used in various fields, such as Oral Solid Dosage Form, Non-Oral Solid Dosage Form and Other,, etc. Oral Solid Dosage Form provides greatest supports to the 3D Printing Drug industry development. In 2022, global % sales of 3D Printing Drug went into Oral Solid Dosage Form filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 3D Printing Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Segment by Type
ZipDose
MED
FDM
SSE
Other
Oral Solid Dosage Form
Non-Oral Solid Dosage Form
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the 3D Printing Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 3D Printing Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 3D Printing Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of 3D Printing Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 3D Printing Drug introduction, etc. 3D Printing Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 3D Printing Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
3D Printing Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global 3D Printing Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oral Solid Dosage Form and Non-Oral Solid Dosage Form are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for 3D Printing Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, 3D Printing Drug key manufacturers include Aprecia Pharmaceuticals, Triastek, FabRx and Multiply Labs, etc. Aprecia Pharmaceuticals, Triastek, FabRx are top 3 players and held % sales share in total in 2022.
3D Printing Drug can be divided into ZipDose, MED, FDM and SSE, etc. ZipDose is the mainstream product in the market, accounting for % sales share globally in 2022.
3D Printing Drug is widely used in various fields, such as Oral Solid Dosage Form, Non-Oral Solid Dosage Form and Other,, etc. Oral Solid Dosage Form provides greatest supports to the 3D Printing Drug industry development. In 2022, global % sales of 3D Printing Drug went into Oral Solid Dosage Form filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 3D Printing Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Segment by Type
ZipDose
MED
FDM
SSE
Other
Segment by Application
Oral Solid Dosage Form
Non-Oral Solid Dosage Form
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the 3D Printing Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 3D Printing Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 3D Printing Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of 3D Printing Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 3D Printing Drug introduction, etc. 3D Printing Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 3D Printing Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices